News 07 mai 2024 UZH researching innovative cancer therapy Researchers from the University of Zurich (UZH) are in the process of developing new cancer therapeutics. Known as radiotheranostics, these drugs...
News 10 abr 2024 Empa researchers develop cellulose-based aerogel A laboratory at the Swiss Federal Laboratories for Materials Science and Technology (Empa) has developed an ultralight, biodegradable and printab...
Actualités 30 abr 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 22 dez 2023 Zynnon hits milestone in the diagnosis of respiratory infections Zynnon has reached a milestone with its technology for diagnosing viral respiratory infections. Following successful studies in hospitals, the co...
News 03 abr 2024 Nouscom receives additional funding for cancer vaccines Nouscom has received an investment totalling 7 million euros from the Italian venture capital firm Angelini Ventures. The Basel-based biotech com...
Aktuell 03 abr 2024 Nouscom erhält weitere Mittel für Krebsimpfstoffe Nouscom hat eine Investition in der Höhe von 7 Millionen Euro von der italienischen Risikokapitalfirma Angelini Ventures erhalten. Damit kann das...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
Actualités 17 abr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 13 set 2023 Zynnon improves diagnosis of respiratory infections in hospitals Zynnon, a life sciences firm based in the canton of Schwyz, has developed a model with the capacity to accurately diagnose and predict viral resp...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
最新 25 dez 2023 瑞士初创公司 Zynnon在呼吸道感染的诊断方面实现突破 Zynnon在诊断病毒性呼吸道感染的技术上实现突破。在医院成功研究后,这家来自大苏黎世地区的公司已开始生产原型。随后还将进行进一步的临床试验。
News 12 jan 2024 Gilde Healthcare acquires majority stake in Swiss Dental Solutions Gilde Healthcare is the new majority shareholder of Swiss Dental Solutions AG, which specializes in biological dentistry. Founder and former owne...
Aktuell 12 jan 2024 Gilde Healthcare übernimmt Mehrheit an Swiss Dental Solutions Gilde Healthcare ist neuer Mehrheitseigner der Swiss Dental Solutions AG, die sich der biologischen Zahnmedizin widmet. Deren Gründer und bisheri...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita